European Society for Blood and Marrow Transplantation EBMT
Scientific academy / society / association
Location:
Leiden,
Netherlands (NL)
ISNI: -
ROR: https://ror.org/014wq8057
Show on Map:
Treosulfan conditioning for allogeneic transplantation in multiple myeloma – improved overall survival in first line haematopoietic stem cell transplantation – a large retrospective study by the Chronic Malignancies Working Party of the EBMT (2020)
Gran C, Wang J, Nahi H, Koster L, Gahrton G, Einsele H, Niittyvoupio R, et al.
Journal article
Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT (2020)
Schmidt-Hieber M, Engelhard D, Ullmann A, Ljungman P, Maertens J, Martino R, Rovira M, et al.
Journal article
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis (2019)
Robin M, De Wreede LC, Wolschke C, Schetelig J, Eikema DJ, Van Lint MT, Knelange NS, et al.
Journal article
Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic Anemia (2019)
Rice C, Eikema DJ, Marsh JCW, Knol C, Hebert K, Putter H, Peterson E, et al.
Journal article
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma (2018)
Garderet L, Iacobelli S, Koster L, Goldschmidt H, Johansson JE, Bourhis JH, Krejci M, et al.
Journal article
Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report (2018)
Sahebi F, Garderet L, Kanate AS, Eikema DJ, Knelange NS, Alvelo OF, Koc Y, et al.
Journal article